[NBIX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
01-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -46.81%
YoY- 139.06%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 378,200 310,600 312,000 296,000 288,900 236,600 247,900 32.62%
PBT -23,300 21,400 -13,800 30,500 57,500 27,200 41,700 -
Tax -6,400 7,500 -6,500 8,000 15,200 -4,900 -306,200 -92.46%
NP -16,900 13,900 -7,300 22,500 42,300 32,100 347,900 -
Tax Rate - -35.05% - -26.23% -26.43% 18.01% 734.29% -
Total Cost 395,100 296,700 319,300 273,500 246,600 204,500 -100,000 -
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -4.47 4.48 -2.34 7.60 14.64 13.57 140.34 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.18 0.15 -0.08 0.24 0.45 0.34 3.72 -
EPS Diluted -0.18 0.14 -0.08 0.23 0.43 0.33 3.58 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.